Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.86 trillion, total revenue of $4.7 trillion and a weighted average PE ratio of 49.19.
Market Cap
9.86T
Revenue
4.7T
Profits
200.43B
PE Ratio
49.19
Profit Margin
4.26%
Dividend Yield
0.38%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.26T | -0.11% | 2,841,275 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 640.75B | -1.62% | 6,507,542 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 505.40B | -0.98% | 5,367,645 | 66.01B |
| 4 | UNH | UnitedHealth Group Incorporated | 363.02B | 1.00% | 4,060,062 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 356.93B | -2.49% | 8,894,410 | 67.38B |
| 6 | NVS | Novartis AG | 302.63B | -1.40% | 1,342,526 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 286.35B | -1.45% | 3,885,246 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 258.75B | 2.30% | 1,653,783 | 47.35B |
| 9 | AMGN | Amgen Inc. | 249.37B | -0.90% | 2,381,954 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 207.72B | -1.68% | 6,606,702 | 30.99B |
| 11 | ABT | Abbott Laboratories | 189.30B | -0.69% | 7,303,187 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 178.60B | -0.64% | 12,216,048 | 50.70B |
| 13 | PFE | Pfizer Inc. | 170.99B | -2.18% | 53,059,340 | 63.63B |
| 14 | DHR | Danaher Corporation | 161.89B | 0.94% | 2,688,095 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 152.78B | 0.89% | 1,744,341 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 134.53B | -4.05% | 2,373,648 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 126.14B | -2.08% | 10,292,730 | 50.03B |
| 18 | MDT | Medtronic plc | 121.04B | -0.41% | 6,822,122 | 37.54B |
| 19 | SYK | Stryker Corporation | 118.22B | 1.22% | 2,588,462 | 26.30B |
| 20 | CVS | CVS Health Corporation | 116.91B | 3.28% | 19,630,049 | 412.65B |
| 21 | MCK | McKesson Corporation | 116.55B | 0.12% | 691,208 | 410.98B |
| 22 | SNY | Sanofi | 108.60B | -0.48% | 5,630,471 | 57.89B |
| 23 | GSK | GSK plc | 98.30B | -0.88% | 3,112,097 | 44.53B |
| 24 | REGN | Regeneron Pharmaceuticals, Inc. | 97.67B | 1.26% | 1,200,307 | 16.90B |
| 25 | HCA | HCA Healthcare, Inc. | 96.69B | -1.04% | 991,137 | 78.70B |
| 26 | MRNA | Moderna, Inc. | 91.20B | 3.45% | 9,515,743 | 2.23B |
| 27 | ELV | Elevance Health, Inc. | 89.39B | 0.04% | 917,419 | 201.83B |
| 28 | CI | The Cigna Group | 78.07B | 0.08% | 1,860,554 | 282.38B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 67.28B | -0.57% | 2,575,641 | 29.86B |
| 30 | COR | Cencora, Inc. | 64.98B | 0.79% | 1,647,898 | 332.77B |
| 31 | BSX | Boston Scientific Corporation | 63.04B | -1.85% | 18,889,705 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 58.57B | -0.55% | 1,675,747 | 254.25B |
| 33 | NTRA | Natera, Inc. | 56.02B | 2.56% | 3,881,474 | 2.71B |
| 34 | ARGX | argenx SE | 55.22B | 2.99% | 432,226 | 5.92B |
| 35 | EW | Edwards Lifesciences Corporation | 54.87B | 2.07% | 6,559,255 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 53.98B | -0.22% | 1,957,832 | 22.48B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 52.94B | 0.06% | 1,188,052 | 4.66B |
| 38 | HUM | Humana Inc. | 50.18B | 1.82% | 1,368,572 | 145.68B |
| 39 | A | Agilent Technologies, Inc. | 49.47B | 2.02% | 2,124,989 | 7.37B |
| 40 | VEEV | Veeva Systems Inc. | 49.09B | -1.23% | 1,419,748 | 3.46B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 48.84B | 2.97% | 11,672,092 | 17.23B |
| 42 | WAT | Waters Corporation | 45.18B | 2.31% | 1,793,429 | 5.61B |
| 43 | MDLN | Medline Inc. | 44.82B | 1.37% | 14,979,119 | 29.94B |
| 44 | IQV | IQVIA Holdings Inc. | 43.27B | 1.61% | 1,321,651 | 17.31B |
| 45 | RVMD | Revolution Medicines, Inc. | 41.63B | 3.22% | 1,439,990 | - |
| 46 | ONC | BeOne Medicines AG | 40.36B | -1.74% | 475,205 | 6.13B |
| 47 | HLN | Haleon plc | 38.48B | 0.91% | 31,984,190 | 14.80B |
| 48 | RPRX | Royalty Pharma plc | 38.18B | -0.18% | 3,175,451 | 2.54B |
| 49 | BIIB | Biogen Inc. | 36.80B | -0.03% | 1,057,629 | 10.30B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 36.47B | 1.40% | 5,491,407 | 21.64B |
| 51 | ILMN | Illumina, Inc. | 36.02B | 5.13% | 2,232,176 | 4.54B |
| 52 | ALC | Alcon Inc. | 35.25B | -1.71% | 1,916,364 | 10.86B |
| 53 | ZTS | Zoetis Inc. | 34.29B | -0.23% | 3,726,246 | 9.53B |
| 54 | MTD | Mettler-Toledo International Inc. | 34.02B | 1.18% | 189,087 | 4.13B |
| 55 | CNC | Centene Corporation | 33.41B | 1.43% | 4,739,840 | 180.41B |
| 56 | GMAB | Genmab A/S | 33.29B | 1.09% | 3,060,842 | 4.13B |
| 57 | RMD | ResMed Inc. | 31.94B | -2.52% | 2,161,195 | 5.73B |
| 58 | DXCM | DexCom, Inc. | 30.94B | -2.11% | 4,125,018 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 28.74B | -0.47% | 717,241 | 14.59B |
| 60 | WST | West Pharmaceutical Services, Inc. | 28.35B | -0.22% | 1,075,766 | 3.40B |
| 61 | PHG | Koninklijke Philips N.V. | 28.12B | 3.15% | 2,094,870 | 20.16B |
| 62 | DGX | Quest Diagnostics Incorporated | 27.18B | -1.50% | 1,064,528 | 11.84B |
| 63 | ROIV | Roivant Sciences Ltd. | 26.03B | 0.42% | 6,686,627 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 25.79B | 0.87% | 611,879 | 3.15B |
| 65 | INCY | Incyte Corporation | 23.97B | -2.04% | 2,171,795 | 6.01B |
| 66 | GH | Guardant Health, Inc. | 23.48B | 2.50% | 1,850,716 | 1.18B |
| 67 | INSM | Insmed Incorporated | 22.91B | -4.46% | 6,216,188 | 1.52B |
| 68 | STE | STERIS plc | 22.56B | -0.86% | 709,159 | 6.04B |
| 69 | BNTX | BioNTech SE | 21.83B | -0.70% | 1,152,383 | 2.75B |
| 70 | VTRS | Viatris Inc. | 21.73B | 1.34% | 7,550,135 | 14.74B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.42B | 1.20% | 3,790,863 | 5.01B |
| 72 | THC | Tenet Healthcare Corporation | 21.23B | -0.82% | 1,262,342 | 22.15B |
| 73 | MEDP | Medpace Holdings, Inc. | 18.56B | 2.37% | 229,527 | 2.84B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 18.51B | -0.30% | 3,026,542 | 8.51B |
| 75 | RVTY | Revvity, Inc. | 18.24B | 7.84% | 3,372,576 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 17.64B | 3.11% | 3,849,479 | 2.50B |
| 77 | CRL | Charles River Laboratories International, Inc. | 16.80B | 3.94% | 1,595,810 | 4.00B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 16.76B | 13.42% | 4,057,212 | 3.70B |
| 79 | ASND | Ascendis Pharma A/S | 16.43B | 0.48% | 618,645 | 1.20B |
| 80 | ICLR | ICON Public Limited Company | 15.27B | -0.67% | 1,096,471 | 8.23B |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 14.91B | 7.13% | 1,680,859 | 4.72B |
| 82 | HALO | Halozyme Therapeutics, Inc. | 14.60B | -0.26% | 1,495,559 | 1.66B |
| 83 | BTSG | BrightSpring Health Services, Inc. | 14.55B | 5.40% | 4,173,629 | 15.25B |
| 84 | SOLV | Solventum Corporation | 14.43B | 0.01% | 1,006,234 | 8.31B |
| 85 | BBIO | BridgeBio Pharma, Inc. | 14.42B | -1.29% | 2,479,157 | 945.54M |
| 86 | TEM | Tempus AI, Inc. | 14.16B | -0.87% | 6,360,154 | 1.51B |
| 87 | GKOS | Glaukos Corporation | 13.79B | -2.33% | 10,738,723 | 690.33M |
| 88 | EHC | Encompass Health Corporation | 13.30B | -1.75% | 1,376,323 | 6.34B |
| 89 | BAX | Baxter International Inc. | 13.19B | 5.24% | 9,397,478 | 11.61B |
| 90 | SMMT | Summit Therapeutics Inc. | 12.64B | 6.76% | 6,045,173 | - |
| 91 | PEN | Penumbra, Inc. | 12.61B | -0.41% | 425,791 | 1.56B |
| 92 | SNN | Smith & Nephew plc | 12.55B | -0.23% | 2,536,680 | 6.30B |
| 93 | ELAN | Elanco Animal Health Incorporated | 12.28B | 1.95% | 6,460,441 | 5.02B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 12.05B | 1.20% | 2,656,058 | 3.44B |
| 95 | FMS | Fresenius Medical Care AG | 11.58B | -3.89% | 2,025,105 | 22.12B |
| 96 | COO | The Cooper Companies, Inc. | 11.57B | -0.77% | 2,204,023 | 4.24B |
| 97 | DVA | DaVita Inc. | 11.46B | -1.92% | 755,679 | 14.17B |
| 98 | RGEN | Repligen Corporation | 11.40B | 3.08% | 1,019,569 | 805.61M |
| 99 | TECH | Bio-Techne Corporation | 11.39B | -0.01% | 3,512,154 | 1.22B |
| 100 | KYMR | Kymera Therapeutics, Inc. | 10.85B | -0.33% | 1,401,505 | 102.24M |
| 101 | MOH | Molina Healthcare, Inc. | 10.83B | -0.29% | 1,032,193 | 42.08B |
| 102 | BMRN | BioMarin Pharmaceutical Inc. | 10.77B | -3.10% | 4,698,502 | 3.66B |
| 103 | ALGN | Align Technology, Inc. | 10.77B | -1.65% | 613,763 | 4.16B |
| 104 | PODD | Insulet Corporation | 10.74B | 0.81% | 1,619,643 | 3.05B |
| 105 | GMED | Globus Medical, Inc. | 10.68B | 0.15% | 1,421,112 | 3.14B |
| 106 | AVTR | Avantor, Inc. | 10.56B | -0.13% | 8,756,786 | 6.64B |
| 107 | ENSG | The Ensign Group, Inc. | 10.54B | 1.76% | 613,897 | 5.67B |
| 108 | UHS | Universal Health Services, Inc. | 10.44B | -1.95% | 653,054 | 18.35B |
| 109 | QGEN | Qiagen N.V. | 10.42B | 0.06% | 7,345,956 | 2.10B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 10.02B | 2.39% | 214,423 | 2.59B |
| 111 | OSCR | Oscar Health, Inc. | 9.99B | 4.55% | 4,398,615 | 15.32B |
| 112 | PCVX | Vaxcyte, Inc. | 9.57B | 0.31% | 2,176,572 | - |
| 113 | HNGE | Hinge Health, Inc. | 9.43B | 1.18% | 4,186,026 | 800.82M |
| 114 | CAI | Caris Life Sciences, Inc. | 9.28B | 2.34% | 2,676,024 | 989.61M |
| 115 | SYRE | Spyre Therapeutics, Inc. | 9.28B | 3.94% | 904,899 | - |
| 116 | HSIC | Henry Schein, Inc. | 9.19B | -4.76% | 4,417,635 | 13.60B |
| 117 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.16B | -8.08% | 1,979,229 | 1.43B |
| 118 | PTGX | Protagonist Therapeutics, Inc. | 9.07B | 0.62% | 674,723 | 281.99M |
| 119 | KRYS | Krystal Biotech, Inc. | 9.04B | 3.09% | 603,125 | 470.03M |
| 120 | ATR | AptarGroup, Inc. | 9.02B | -1.08% | 668,815 | 3.99B |
| 121 | CORT | Corcept Therapeutics Incorporated | 8.86B | 1.83% | 1,524,295 | 963.65M |
| 122 | TWST | Twist Bioscience Corporation | 8.80B | 8.73% | 1,941,092 | 431.80M |
| 123 | IBRX | ImmunityBio, Inc. | 8.79B | 4.28% | 6,190,474 | 165.79M |
| 124 | CYTK | Cytokinetics, Incorporated | 8.66B | 0.45% | 1,699,316 | 67.67M |
| 125 | TGTX | TG Therapeutics, Inc. | 8.62B | 1.33% | 2,147,816 | 799.54M |
| 126 | BRKR | Bruker Corporation | 8.61B | 1.45% | 4,339,546 | 3.50B |
| 127 | TXG | 10x Genomics, Inc. | 8.51B | 5.94% | 2,631,266 | 616.91M |
| 128 | HQY | HealthEquity, Inc. | 8.44B | -1.58% | 942,161 | 1.36B |
| 129 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.41B | -0.07% | 1,327,200 | 669.50M |
| 130 | PRAX | Praxis Precision Medicines, Inc. | 7.83B | 2.38% | 220,549 | 7.46M |
| 131 | ABVX | ABIVAX Société Anonyme | 7.73B | 4.48% | 585,619 | 5.33M |
| 132 | ALKS | Alkermes plc | 7.67B | 1.78% | 2,328,628 | 1.75B |
| 133 | GRFS | Grifols, S.A. | 7.56B | 0.59% | 1,003,386 | 8.63B |
| 134 | PACS | PACS Group, Inc. | 7.39B | 2.41% | 802,864 | 5.71B |
| 135 | AXSM | Axsome Therapeutics, Inc. | 7.34B | 2.65% | 1,679,570 | 865.27M |
| 136 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.33B | 2.74% | 1,022,125 | 945.96M |
| 137 | BLCO | Bausch + Lomb Corporation | 7.16B | 0.10% | 682,628 | 5.42B |
| 138 | AMRX | Amneal Pharmaceuticals, Inc. | 7.04B | -1.13% | 6,440,045 | 3.20B |
| 139 | CHE | Chemed Corporation | 6.92B | -1.57% | 223,920 | 2.66B |
| 140 | IONS | Ionis Pharmaceuticals, Inc. | 6.72B | -1.99% | 4,006,910 | 874.09M |
| 141 | ORKA | Oruka Therapeutics, Inc. | 6.59B | 4.32% | 822,164 | - |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.58B | 0.49% | 748,575 | 1.56B |
| 143 | LGND | Ligand Pharmaceuticals Incorporated | 6.27B | 2.12% | 195,587 | 253.83M |
| 144 | GRAL | GRAIL, Inc. | 6.23B | 4.25% | 1,272,940 | 165.26M |
| 145 | KOD | Kodiak Sciences Inc. | 6.20B | 1.29% | 803,490 | - |
| 146 | BLTE | Belite Bio, Inc | 6.13B | -0.98% | 149,875 | - |
| 147 | IMVT | Immunovant, Inc. | 6.00B | 2.22% | 1,079,791 | - |
| 148 | HIMS | Hims & Hers Health, Inc. | 6.00B | 1.82% | 7,425,100 | 2.58B |
| 149 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.95B | -7.49% | 7,110,007 | 280.75M |
| 150 | TFX | Teleflex Incorporated | 5.93B | -0.51% | 1,266,151 | 2.25B |
| 151 | DOCS | Doximity, Inc. | 5.81B | -0.82% | 2,152,222 | 655.57M |
| 152 | RDNT | RadNet, Inc. | 5.76B | 0.11% | 988,534 | 2.27B |
| 153 | PTCT | PTC Therapeutics, Inc. | 5.69B | 11.89% | 2,643,741 | 1.16B |
| 154 | CGON | CG Oncology, Inc. | 5.68B | 3.39% | 724,759 | 6.23M |
| 155 | MIRM | Mirum Pharmaceuticals, Inc. | 5.65B | 1.50% | 635,550 | 670.78M |
| 156 | MANE | Veradermics, Incorporated | 5.58B | 3.15% | 536,307 | - |
| 157 | HAE | Haemonetics Corporation | 5.47B | 0.12% | 834,603 | 1.35B |
| 158 | COGT | Cogent Biosciences, Inc. | 5.39B | 4.47% | 1,876,717 | - |
| 159 | SRRK | Scholar Rock Holding Corporation | 5.36B | 2.49% | 676,834 | - |
| 160 | MMED | MiniMed Group, Inc. | 5.30B | -0.26% | 5,713,749 | 3.22B |
| 161 | WAY | Waystar Holding Corp. | 5.30B | -1.72% | 3,912,322 | 1.26B |
| 162 | BLLN | BillionToOne, Inc. | 5.21B | 0.04% | 360,373 | 397.41M |
| 163 | ERAS | Erasca, Inc. | 5.12B | 4.20% | 3,798,385 | - |
| 164 | CON | Concentra Group Holdings Parent, Inc. | 5.12B | -0.45% | 1,068,215 | 2.29B |
| 165 | LFST | LifeStance Health Group, Inc. | 5.11B | 0.83% | 3,026,498 | 1.58B |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.04B | -0.18% | 851,041 | 1.61B |
| 167 | CRSP | CRISPR Therapeutics AG | 4.83B | - | 1,291,868 | 25.17M |
| 168 | OPCH | Option Care Health, Inc. | 4.76B | 0.25% | 3,377,188 | 5.69B |
| 169 | HTFL | HeartFlow, Inc. | 4.73B | -0.17% | 1,468,343 | 212.07M |
| 170 | TVTX | Travere Therapeutics, Inc. | 4.66B | 0.30% | 9,080,285 | 651.03M |
| 171 | CDNA | CareDx, Inc. | 4.65B | 3.02% | 1,589,202 | 497.40M |
| 172 | DNTH | Dianthus Therapeutics, Inc. | 4.63B | 0.55% | 1,530,539 | 1.90M |
| 173 | SHC | Sotera Health Company | 4.57B | -9.64% | 5,361,188 | 1.23B |
| 174 | DFTX | Definium Therapeutics, Inc. | 4.49B | 2.89% | 1,724,242 | - |
| 175 | LIVN | LivaNova PLC | 4.40B | -0.39% | 946,620 | 1.47B |
| 176 | ITGR | Integer Holdings Corporation | 4.30B | - | 732,662 | 1.83B |
| 177 | IRTC | iRhythm Holdings, Inc. | 4.17B | 0.16% | 415,687 | 825.34M |
| 178 | LEGN | Legend Biotech Corporation | 4.16B | 1.80% | 1,644,658 | 1.27B |
| 179 | ADPT | Adaptive Biotechnologies Corporation | 4.12B | 2.95% | 1,512,841 | 308.08M |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 4.09B | -1.13% | 1,878,537 | - |
| 181 | ICUI | ICU Medical, Inc. | 4.05B | -0.34% | 297,798 | 2.16B |
| 182 | VCYT | Veracyte, Inc. | 4.04B | 2.63% | 1,082,208 | 561.90M |
| 183 | ARQT | Arcutis Biotherapeutics, Inc. | 4.02B | 2.37% | 1,617,403 | 463.98M |
| 184 | IOVA | Iovance Biotherapeutics, Inc. | 4.00B | 10.10% | 14,150,913 | 324.97M |
| 185 | NVST | Envista Holdings Corporation | 3.98B | 0.24% | 5,526,713 | 2.86B |
| 186 | ABCL | AbCellera Biologics Inc. | 3.95B | 9.53% | 2,502,034 | 66.17M |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.91B | 6.48% | 2,458,056 | 53.81M |
| 188 | STVN | Stevanato Group S.p.A. | 3.85B | -28.57% | 4,785,286 | 1.42B |
| 189 | RLAY | Relay Therapeutics, Inc. | 3.82B | 0.93% | 3,176,098 | 10.35M |
| 190 | LQDA | Liquidia Corporation | 3.78B | 0.84% | 2,182,320 | 450.91M |
| 191 | PLSE | Pulse Biosciences, Inc. | 3.72B | -1.32% | 386,076 | 1.19M |
| 192 | XENE | Xenon Pharmaceuticals Inc. | 3.70B | 1.62% | 1,246,675 | 7.50M |
| 193 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.66B | 4.14% | 1,202,707 | -665.00K |
| 194 | OGN | Organon & Co. | 3.64B | 0.22% | 3,657,927 | 6.10B |
| 195 | PBLS | Parabilis Medicines, Inc. | 3.61B | 7.34% | 519,455 | 148.00K |
| 196 | IRON | Disc Medicine, Inc. | 3.60B | 3.23% | 1,543,756 | - |
| 197 | ACAD | Acadia Pharmaceuticals Inc. | 3.54B | 0.49% | 1,709,206 | 1.14B |
| 198 | CELC | Celcuity Inc. | 3.41B | 3.95% | 1,130,603 | - |
| 199 | DYN | Dyne Therapeutics, Inc. | 3.37B | 4.34% | 2,815,819 | - |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.33B | -2.76% | 2,743,018 | - |
| 201 | SPUN | Indivior Pharmaceuticals, Inc. | 3.32B | -22.41% | 9,049,886 | 1.37B |
| 202 | SUPN | Supernus Pharmaceuticals, Inc. | 3.32B | -16.69% | 9,053,153 | 1.37B |
| 203 | ELVN | Enliven Therapeutics, Inc. | 3.28B | 0.45% | 2,125,586 | - |
| 204 | NHC | National HealthCare Corporation | 3.22B | 1.85% | 148,720 | 1.56B |
| 205 | TARS | Tarsus Pharmaceuticals, Inc. | 3.19B | -0.93% | 755,780 | 682.20M |
| 206 | TLX | Telix Pharmaceuticals Limited | 3.15B | -0.22% | 174,897 | 890.79M |
| 207 | DNLI | Denali Therapeutics Inc. | 3.11B | 3.13% | 2,426,008 | 21.38M |
| 208 | ATRC | AtriCure, Inc. | 3.07B | 0.89% | 1,606,810 | 589.80M |
| 209 | RGC | Regencell Bioscience Holdings Limited | 3.05B | -2.23% | 94,913 | - |
| 210 | BHC | Bausch Health Companies Inc. | 3.05B | 1.50% | 3,422,162 | 11.11B |
| 211 | IDYA | IDEAYA Biosciences, Inc. | 3.02B | -0.98% | 1,888,003 | 36.54M |
| 212 | SGRY | Surgery Partners, Inc. | 3.00B | 0.04% | 2,391,974 | 3.37B |
| 213 | AXGN | Axogen, Inc. | 2.96B | -0.70% | 1,046,432 | 266.93M |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 2.90B | 1.22% | 1,992,834 | 2.60B |
| 215 | VRDN | Viridian Therapeutics, Inc. | 2.85B | -0.59% | 4,062,998 | 71.13M |
| 216 | NRIX | Nurix Therapeutics, Inc. | 2.82B | 0.47% | 4,386,940 | 701.94M |
| 217 | ACHC | Acadia Healthcare Company, Inc. | 2.76B | - | 1,578,786 | 3.37B |
| 218 | PRVA | Privia Health Group, Inc. | 2.74B | 0.89% | 1,255,481 | 2.36B |
| 219 | ZLAB | Zai Lab Limited | 2.73B | 1.34% | 2,523,021 | 449.61M |
| 220 | RCUS | Arcus Biosciences, Inc. | 2.72B | 5.94% | 1,935,572 | 117.00M |
| 221 | WRBY | Warby Parker Inc. | 2.71B | -8.05% | 4,381,984 | 911.61M |
| 222 | MBX | MBX Biosciences, Inc. | 2.65B | 1.10% | 287,590 | - |
| 223 | NEOG | Neogen Corporation | 2.64B | 2.37% | 2,360,283 | 884.00M |
| 224 | BEAM | Beam Therapeutics Inc. | 2.63B | 1.78% | 1,434,271 | 146.64M |
| 225 | GRDN | Guardian Pharmacy Services, Inc. | 2.59B | 2.17% | 496,552 | 1.46B |
| 226 | ADMA | ADMA Biologics, Inc. | 2.49B | 0.45% | 5,055,804 | 512.28M |
| 227 | BKD | Brookdale Senior Living Inc. | 2.48B | -0.67% | 5,058,014 | 2.93B |
| 228 | PHVS | Pharvaris N.V. | 2.44B | 3.73% | 577,202 | - |
| 229 | IMNM | Immunome, Inc. | 2.40B | 3.68% | 1,853,938 | 4.02M |
| 230 | NAMS | NewAmsterdam Pharma Company N.V. | 2.38B | 1.74% | 2,071,939 | 7.12M |
| 231 | HCM | HUTCHMED (China) Limited | 2.38B | -1.43% | 28,849 | 549.12M |
| 232 | BHVN | Biohaven Ltd. | 2.36B | 2.97% | 2,016,838 | - |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.35B | -0.38% | 610,524 | 1.10B |
| 234 | TMDX | TransMedics Group, Inc. | 2.34B | 1.00% | 706,843 | 668.47M |
| 235 | CLDX | Celldex Therapeutics, Inc. | 2.33B | 2.31% | 872,045 | 158.00K |
| 236 | MD | Pediatrix Medical Group, Inc. | 2.33B | -0.36% | 1,180,098 | 1.96B |
| 237 | ADUS | Addus HomeCare Corporation | 2.32B | 0.64% | 455,470 | 1.50B |
| 238 | CLOV | Clover Health Investments, Corp. | 2.28B | -0.46% | 4,601,175 | 2.48B |
| 239 | XNCR | Xencor, Inc. | 2.28B | 3.30% | 1,220,293 | 104.97M |
| 240 | PGNY | Progyny, Inc. | 2.23B | -1.19% | 1,028,192 | 1.31B |
| 241 | TRLV | Trulieve Cannabis Corp. | 2.22B | 3.96% | 1,348,410 | 1.14B |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.22B | 2.60% | 1,183,769 | 321.74M |
| 243 | VERA | Vera Therapeutics, Inc. | 2.21B | 1.52% | 1,579,587 | - |
| 244 | PVLA | Palvella Therapeutics, Inc. | 2.20B | 4.51% | 339,565 | - |
| 245 | RXRX | Recursion Pharmaceuticals, Inc. | 2.20B | -3.92% | 20,780,779 | 68.23M |
| 246 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.19B | 3.88% | 6,532,991 | 940.61M |
| 247 | PRGO | Perrigo Company plc | 2.18B | -0.32% | 2,146,726 | 4.14B |
| 248 | NEO | NeoGenomics, Inc. | 2.18B | 2.06% | 1,810,146 | 787.75M |
| 249 | UFPT | UFP Technologies, Inc. | 2.17B | -1.29% | 152,360 | 649.52M |
| 250 | HRMY | Harmony Biosciences Holdings, Inc. | 2.16B | -2.35% | 1,445,202 | 959.90M |
| 251 | ZYME | Zymeworks Inc. | 2.14B | 3.93% | 2,519,662 | 37.13M |
| 252 | VCEL | Vericel Corporation | 2.10B | 1.43% | 635,185 | 306.30M |
| 253 | ALMR | Alamar Biosciences, Inc. | 2.10B | 4.42% | 674,042 | 114.05M |
| 254 | LKFT | Lakefront Biotherapeutics NV | 2.06B | 0.41% | 129,706 | 1.13B |
| 255 | WGS | GeneDx Holdings Corp. | 2.05B | 7.10% | 667,554 | 454.43M |
| 256 | SEPN | Septerna, Inc. | 2.04B | 1.16% | 307,511 | 98.88M |
| 257 | SDGR | Schrödinger, Inc. | 2.03B | 3.78% | 1,212,811 | 259.04M |
| 258 | FTRE | Fortrea Holdings Inc. | 2.02B | 4.65% | 1,578,240 | 2.67B |
| 259 | COAG | Hemab Therapeutics Holdings, Inc. | 2.01B | 4.66% | 465,845 | - |
| 260 | TRVI | Trevi Therapeutics, Inc. | 1.97B | 1.69% | 1,190,577 | - |
| 261 | SRPT | Sarepta Therapeutics, Inc. | 1.96B | 1.20% | 1,398,499 | 1.97B |
| 262 | REPL | Replimune Group, Inc. | 1.96B | 5.95% | 4,731,031 | - |
| 263 | TRAX | First Tracks Biotherapeutics, Inc. | 1.95B | 2.86% | 410,051 | - |
| 264 | XRAY | DENTSPLY SIRONA Inc. | 1.94B | -1.72% | 3,448,594 | 3.64B |
| 265 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.93B | 3.62% | 1,905,852 | 208.78M |
| 266 | MESO | Mesoblast Limited | 1.90B | 1.58% | 292,497 | 120.25M |
| 267 | VIR | Vir Biotechnology, Inc. | 1.90B | 2.00% | 1,553,545 | 303.23M |
| 268 | XERS | Xeris Biopharma Holdings, Inc. | 1.89B | 1.77% | 3,290,400 | 335.41M |
| 269 | PGEN | Precigen, Inc. | 1.88B | 2.14% | 9,717,818 | 85.72M |
| 270 | ASTH | Astrana Health, Inc. | 1.88B | -0.41% | 379,657 | 3.84B |
| 271 | AGIO | Agios Pharmaceuticals, Inc. | 1.86B | 4.17% | 684,858 | 98.34M |
| 272 | ZBIO | Zenas BioPharma, Inc. | 1.85B | 2.75% | 572,844 | 1.00M |
| 273 | LMAT | LeMaitre Vascular, Inc. | 1.84B | -0.81% | 425,316 | 262.43M |
| 274 | ESTA | Establishment Labs Holdings Inc. | 1.83B | 0.54% | 498,358 | 264.03M |
| 275 | ADRX | ADARx Pharmaceuticals, Inc. | 1.80B | 2.09% | 378,483 | 6.13M |
| 276 | SLS | SELLAS Life Sciences Group, Inc. | 1.79B | 3.74% | 5,052,765 | - |
| 277 | INSP | Inspire Medical Systems, Inc. | 1.79B | -7.90% | 1,522,004 | 880.94M |
| 278 | GENB | Generate Biomedicines, Inc. | 1.78B | 4.84% | 725,548 | 26.48M |
| 279 | AMN | AMN Healthcare Services, Inc. | 1.75B | -1.03% | 926,521 | 3.43B |
| 280 | STOK | Stoke Therapeutics, Inc. | 1.75B | 1.93% | 1,727,622 | 28.21M |
| 281 | BRVE | Braveheart Bio, Inc. | 1.75B | 1.66% | 305,541 | - |
| 282 | MAZE | Maze Therapeutics, Inc. | 1.74B | 6.19% | 488,819 | 20.00M |
| 283 | KMTS | Kestra Medical Technologies, Ltd. | 1.73B | -2.68% | 537,375 | 106.73M |
| 284 | HCSG | Healthcare Services Group, Inc. | 1.72B | -0.74% | 893,314 | 1.88B |
| 285 | ABSI | Absci Corporation | 1.72B | 3.20% | 2,718,888 | 1.56M |
| 286 | BFLY | Butterfly Network, Inc. | 1.71B | 4.23% | 4,050,695 | 123.26M |
| 287 | PSNL | Personalis, Inc. | 1.68B | -0.06% | 2,930,167 | 69.67M |
| 288 | URGN | UroGen Pharma Ltd. | 1.68B | 0.12% | 1,237,809 | 188.73M |
| 289 | NTLA | Intellia Therapeutics, Inc. | 1.66B | 1.72% | 2,886,856 | 59.51M |
| 290 | CERT | Certara, Inc. | 1.66B | 1.49% | 1,869,817 | 421.75M |
| 291 | QURE | uniQure N.V. | 1.66B | 3.92% | 1,838,931 | 18.67M |
| 292 | ARDT | Ardent Health, Inc. | 1.65B | -0.17% | 336,100 | 6.41B |
| 293 | NUVB | Nuvation Bio Inc. | 1.65B | 2.18% | 5,144,862 | 169.90M |
| 294 | RARE | Ultragenyx Pharmaceutical Inc. | 1.63B | 2.02% | 3,709,347 | 730.00M |
| 295 | KLRA | Kailera Therapeutics, Inc. | 1.63B | 3.54% | 775,937 | - |
| 296 | AZTA | Azenta, Inc. | 1.63B | 4.47% | 1,033,472 | 613.81M |
| 297 | TDOC | Teladoc Health, Inc. | 1.62B | 3.01% | 6,106,924 | 2.47B |
| 298 | ALVO | Alvotech | 1.62B | 1.34% | 541,401 | 494.61M |
| 299 | OMCL | Omnicell, Inc. | 1.62B | -2.61% | 890,828 | 1.24B |
| 300 | SNDA | Sonida Senior Living, Inc. | 1.61B | 0.50% | 410,527 | 481.07M |
| 301 | NVAX | Novavax, Inc. | 1.60B | 1.57% | 3,464,750 | 413.80M |
| 302 | LYCA | Lycia Therapeutics, Inc. | 1.59B | 1.55% | 195,320 | 4.44M |
| 303 | NVCR | NovoCure Limited | 1.57B | 1.67% | 1,652,351 | 725.39M |
| 304 | ANIP | ANI Pharmaceuticals, Inc. | 1.55B | 2.28% | 371,252 | 978.38M |
| 305 | IMCR | Immunocore Holdings plc | 1.55B | 0.81% | 252,839 | 430.78M |
| 306 | ALHC | Alignment Healthcare, Inc. | 1.55B | 5.57% | 5,627,361 | 4.94B |
| 307 | PAHC | Phibro Animal Health Corporation | 1.53B | -2.81% | 289,490 | 1.52B |
| 308 | INVA | Innoviva, Inc. | 1.51B | -0.43% | 712,646 | 440.00M |
| 309 | RAPP | Rapport Therapeutics, Inc. | 1.51B | 1.23% | 823,477 | 20.00M |
| 310 | OCUL | Ocular Therapeutix, Inc. | 1.50B | 1.34% | 2,001,473 | 52.06M |
| 311 | AGL | agilon health, inc. | 1.47B | 1.34% | 329,714 | 5.92B |
| 312 | TYRA | Tyra Biosciences, Inc. | 1.47B | 0.19% | 433,758 | - |
| 313 | ETON | Eton Pharmaceuticals, Inc. | 1.46B | 0.28% | 340,603 | 105.60M |
| 314 | KRSA | Korsana Biosciences, Inc. | 1.46B | 0.95% | 152,099 | - |
| 315 | NBTX | Nanobiotix S.A. | 1.45B | 1.60% | 167,790 | 13.15M |
| 316 | GPCR | Structure Therapeutics Inc. | 1.45B | -0.59% | 612,885 | - |
| 317 | PCRX | Pacira BioSciences, Inc. | 1.45B | -0.03% | 1,075,429 | 746.16M |
| 318 | PNTG | The Pennant Group, Inc. | 1.44B | 1.70% | 219,180 | 1.10B |
| 319 | ANAB | AnaptysBio, Inc. | 1.43B | 1.75% | 304,855 | 106.09M |
| 320 | MLYS | Mineralys Therapeutics, Inc. | 1.41B | 2.83% | 2,607,085 | - |
| 321 | CNMD | CONMED Corporation | 1.41B | 1.37% | 510,103 | 1.37B |
| 322 | GHRS | GH Research PLC | 1.39B | -1.07% | 476,163 | - |
| 323 | DMRA | Damora Therapeutics, Inc. | 1.36B | 2.22% | 473,168 | - |
| 324 | KARD | Kardigan, Inc. | 1.34B | 0.77% | 545,036 | - |
| 325 | TSHA | Taysha Gene Therapies, Inc. | 1.33B | 2.25% | 1,728,943 | 5.49M |
| 326 | AAPG | Ascentage Pharma Group International | 1.33B | -0.59% | 1,822 | 94.61M |
| 327 | OMER | Omeros Corporation | 1.32B | 2.47% | 887,385 | 38.42M |
| 328 | LBRX | LB Pharmaceuticals Inc | 1.30B | 3.30% | 245,838 | - |
| 329 | NKTR | Nektar Therapeutics | 1.29B | 2.19% | 429,007 | 54.59M |
| 330 | OPK | OPKO Health, Inc. | 1.28B | - | 4,156,999 | 587.90M |
| 331 | SNDX | Syndax Pharmaceuticals, Inc. | 1.28B | 9.08% | 4,975,399 | 289.68M |
| 332 | USPH | U.S. Physical Therapy, Inc. | 1.26B | -0.19% | 191,153 | 804.27M |
| 333 | STAA | STAAR Surgical Company | 1.26B | 0.92% | 691,154 | 339.59M |
| 334 | CRON | Cronos Group Inc. | 1.25B | 1.50% | 1,124,880 | 179.09M |
| 335 | DRTS | Alpha Tau Medical Ltd. | 1.25B | 5.53% | 663,396 | - |
| 336 | FRNM | Freenome, Inc. | 1.23B | -1.21% | 539,139 | 35.41M |
| 337 | NUTX | Nutex Health Inc. | 1.23B | -3.24% | 180,232 | 846.72M |
| 338 | TNDM | Tandem Diabetes Care, Inc. | 1.23B | -5.46% | 2,567,395 | 1.04B |
| 339 | VOR | Vor Biopharma Inc. | 1.22B | 3.17% | 906,174 | - |
| 340 | INNV | InnovAge Holding Corp. | 1.21B | -0.78% | 720,910 | 1.02B |
| 341 | SVRA | Savara Inc. | 1.21B | 0.42% | 2,110,957 | - |
| 342 | ENOV | Enovis Corporation | 1.20B | 1.31% | 1,944,504 | 2.30B |
| 343 | MNKD | MannKind Corporation | 1.20B | 2.19% | 4,868,078 | 393.63M |
| 344 | INBX | Inhibrx Biosciences, Inc. | 1.19B | 12.36% | 600,239 | 1.30M |
| 345 | SLN | Silence Therapeutics plc | 1.19B | 0.10% | 352,416 | 615.00K |
| 346 | GDRX | GoodRx Holdings, Inc. | 1.19B | -1.69% | 1,064,102 | 785.23M |
| 347 | CMPS | COMPASS Pathways plc | 1.19B | 2.14% | 8,845,431 | - |
| 348 | AVLN | Avalyn Pharma Inc. | 1.19B | 4.73% | 450,176 | - |
| 349 | VSTM | Verastem, Inc. | 1.19B | 1.88% | 2,746,462 | 87.53M |
| 350 | ATEC | Alphatec Holdings, Inc. | 1.16B | 2.19% | 6,701,040 | 839.72M |
| 351 | AORT | Artivion, Inc. | 1.16B | 0.55% | 645,727 | 471.47M |
| 352 | PRCT | PROCEPT BioRobotics Corporation | 1.16B | 3.76% | 1,295,981 | 337.34M |
| 353 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.15B | 0.33% | 550,214 | 730.02M |
| 354 | SGP | SpyGlass Pharma, Inc. | 1.15B | 2.41% | 191,550 | - |
| 355 | OMDA | Omada Health, Inc. | 1.14B | 4.09% | 927,027 | 309.76M |
| 356 | JANX | Janux Therapeutics, Inc. | 1.09B | 2.06% | 769,312 | 24.00M |
| 357 | CBLL | CeriBell, Inc. | 1.08B | 4.86% | 689,002 | 108.72M |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.08B | 0.95% | 393,650 | - |
| 359 | LMRI | Lumexa Imaging Holdings, Inc. | 1.08B | 0.63% | 251,904 | 1.04B |
| 360 | CSTL | Castle Biosciences, Inc. | 1.07B | 0.57% | 455,614 | 357.28M |
| 361 | HROW | Harrow, Inc. | 1.07B | 1.21% | 625,375 | 275.59M |
| 362 | SIBN | SI-BONE, Inc. | 1.07B | 17.56% | 3,299,131 | 220.65M |
| 363 | IART | Integra LifeSciences Holdings Corporation | 1.06B | 0.15% | 1,693,410 | 1.66B |
| 364 | IRMD | IRADIMED CORPORATION | 1.04B | 2.13% | 169,100 | 89.34M |
| 365 | AHG | Akso Health Group | 1.04B | -7.84% | 2,707 | 13.83M |
| 366 | ODTX | Odyssey Therapeutics, Inc. | 1.03B | 10.45% | 412,228 | 99.00K |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | 5.49% | 788,706 | - |
| 368 | MLTX | MoonLake Immunotherapeutics | 995.75M | 2.01% | 855,037 | - |
| 369 | ORIC | ORIC Pharmaceuticals, Inc. | 994.03M | 5.73% | 3,555,588 | - |
| 370 | HSTM | HealthStream, Inc. | 968.97M | -8.42% | 810,962 | 327.95M |
| 371 | IMTX | Immatics N.V. | 967.08M | 0.21% | 1,315,752 | 47.65M |
| 372 | QDEL | QuidelOrtho Corporation | 966.23M | 0.43% | 3,574,696 | 2.59B |
| 373 | LTGO | Latigo Biotherapeutics, Inc. | 965.98M | 7.85% | 244,860 | - |
| 374 | CTY | City Therapeutics, Inc. | 949.86M | -8.57% | 275,531 | 14.34M |
| 375 | IVA | Inventiva S.A. | 938.88M | 5.22% | 4,069,577 | 2.81M |
| 376 | JBIO | Jade Biosciences, Inc. | 926.61M | 4.59% | 1,448,882 | - |
| 377 | BVS | Bioventus Inc. | 920.39M | -16.77% | 2,445,541 | 585.64M |
| 378 | MGTX | MeiraGTx Holdings plc | 914.33M | 2.15% | 393,366 | 397.50M |
| 379 | RIGL | Rigel Pharmaceuticals, Inc. | 912.70M | -3.30% | 286,979 | 276.79M |
| 380 | PHAR | Pharming Group N.V. | 898.00M | 1.57% | 21,622 | 386.75M |
| 381 | ANRO | Alto Neuroscience, Inc. | 890.80M | 2.30% | 505,179 | - |
| 382 | GLUE | Monte Rosa Therapeutics, Inc. | 888.11M | -2.07% | 1,363,554 | 28.73M |
| 383 | GMRS | GMR Solutions Inc. | 885.25M | 2.52% | 551,446 | 5.88B |
| 384 | KURA | Kura Oncology, Inc. | 878.93M | 0.92% | 1,202,866 | 77.23M |
| 385 | ALMS | Alumis Inc. | 841.33M | 1.88% | 2,566,618 | 7.40M |
| 386 | AHCO | AdaptHealth Corp. | 837.81M | 6.26% | 7,671,237 | 3.44B |
| 387 | AKTS | Aktis Oncology, Inc. | 830.96M | 2.40% | 579,701 | 10.06M |
| 388 | CRVS | Corvus Pharmaceuticals, Inc. | 826.91M | 1.34% | 776,102 | - |
| 389 | BBNX | Beta Bionics, Inc. | 820.94M | -5.03% | 741,065 | 127.27M |
| 390 | KIDS | OrthoPediatrics Corp. | 820.13M | 3.22% | 642,451 | 264.14M |
| 391 | OBX | Obsidian Therapeutics, Inc. | 817.26M | -8.32% | 626,849 | - |
| 392 | BBTX | Bambusa Therapeutics, Inc. | 815.08M | - | 278,163 | - |
| 393 | PRME | Prime Medicine, Inc. | 809.46M | 2.48% | 4,121,499 | 4.07M |
| 394 | INMD | InMode Ltd. | 809.33M | 2.77% | 668,257 | 374.63M |
| 395 | ANNX | Annexon, Inc. | 794.34M | 6.35% | 4,280,905 | - |
| 396 | VREX | Varex Imaging Corporation | 781.00M | 0.38% | 644,672 | 865.00M |
| 397 | CTKB | Cytek Biosciences, Inc. | 774.70M | 3.29% | 1,241,349 | 206.71M |
| 398 | COLL | Collegium Pharmaceutical, Inc. | 772.54M | 0.21% | 524,868 | 808.21M |
| 399 | ABUS | Arbutus Biopharma Corporation | 767.65M | -3.00% | 2,386,086 | 181.72M |
| 400 | PHR | Phreesia, Inc. | 759.13M | -1.69% | 403,099 | 507.79M |
| 401 | PACB | Pacific Biosciences of California, Inc. | 758.43M | 4.05% | 6,256,512 | 159.27M |
| 402 | ARDX | Ardelyx, Inc. | 755.04M | - | 6,218,044 | 468.22M |
| 403 | OABI | OmniAb, Inc. | 751.18M | 1.18% | 1,575,428 | 40.21M |
| 404 | SANA | Sana Biotechnology, Inc. | 730.44M | 1.67% | 1,819,041 | - |
| 405 | DNA | Ginkgo Bioworks Holdings, Inc. | 724.58M | 9.24% | 2,522,962 | 132.42M |
| 406 | WVE | Wave Life Sciences, Inc. | 706.08M | 1.70% | 3,830,576 | 70.92M |
| 407 | SGMT | Sagimet Biosciences Inc. | 705.54M | 2.68% | 636,839 | - |
| 408 | ATTO | Attovia Therapeutics, Inc. | 697.09M | 1.46% | 156,083 | 1.80M |
| 409 | SLBT | SL Science Holding Limited | 695.72M | -3.94% | 7,446 | 3.27M |
| 410 | ACHV | Achieve Life Sciences, Inc. | 692.53M | 1.82% | 896,728 | - |
| 411 | CADL | Candel Therapeutics, Inc. | 674.89M | 8.62% | 3,304,421 | - |
| 412 | SLDB | Solid Biosciences Inc. | 673.37M | 4.67% | 770,149 | - |
| 413 | FDMT | 4D Molecular Therapeutics, Inc. | 660.17M | 5.10% | 740,405 | 92.01M |
| 414 | HELP | Helus Pharma Inc. | 659.73M | 2.61% | 1,237,070 | - |
| 415 | LXRX | Lexicon Pharmaceuticals, Inc. | 649.64M | 1.39% | 1,036,116 | 41.47M |
| 416 | AURA | Aura Biosciences, Inc. | 647.12M | 3.48% | 643,083 | - |
| 417 | DSGN | Design Therapeutics, Inc. | 647.09M | 1.87% | 233,462 | - |
| 418 | STLN | Starling Oncology, Inc. | 646.15M | 1.44% | 1,013,343 | 587.24M |
| 419 | OLMA | Olema Pharmaceuticals, Inc. | 643.11M | 3.96% | 1,207,436 | - |
| 420 | AVBP | ArriVent BioPharma, Inc. | 641.99M | -2.47% | 1,226,316 | - |
| 421 | IAM | Iambic Therapeutics, Inc. | 639.44M | 4.09% | 220,502 | 18.25M |
| 422 | IMMX | Immix Biopharma, Inc. | 639.18M | 6.20% | 1,072,433 | - |
| 423 | NVCT | Nuvectis Pharma, Inc. | 630.13M | 0.83% | 143,081 | - |
| 424 | DBVT | DBV Technologies S.A. | 628.48M | 11.71% | 323,343 | 3.74M |
| 425 | APMD | Apnimed, Inc. | 626.96M | -2.21% | 575,783 | 115.12M |
| 426 | ANL | Adlai Nortye Group Ltd. | 616.93M | 2.24% | 236,144 | 18.06M |
| 427 | ZVRA | Zevra Therapeutics, Inc. | 609.28M | 1.58% | 690,149 | 147.76M |
| 428 | GERN | Geron Corporation | 597.50M | 0.10% | 58,834,805 | 204.56M |
| 429 | BCAX | Bicara Therapeutics Inc. | 592.91M | 12.99% | 2,328,203 | - |
| 430 | SOPH | SOPHiA GENETICS SA | 588.23M | -2.81% | 2,305,564 | 90.97M |
| 431 | ACRS | Aclaris Therapeutics, Inc. | 579.64M | -1.58% | 1,865,686 | 8.22M |
| 432 | IRWD | Ironwood Pharmaceuticals, Inc. | 578.34M | 1.16% | 1,947,081 | 389.32M |
| 433 | MYGN | Myriad Genetics, Inc. | 577.72M | 3.25% | 2,199,775 | 806.60M |
| 434 | EVO | Evotec SE | 569.02M | 1.97% | 30,112 | 819.47M |
| 435 | TCMD | Tactile Systems Technology, Inc. | 561.32M | 8.35% | 532,211 | 356.42M |
| 436 | CLYM | Climb Bio, Inc. | 560.00M | 0.10% | 887,672 | - |
| 437 | CBIO | Crescent Biopharma, Inc. | 558.98M | 1.16% | 159,532 | 11.88M |
| 438 | STTK | Shattuck Labs, Inc. | 548.99M | 2.82% | 849,983 | 1.00M |
| 439 | AVR | Anteris Technologies Global Corp. | 545.96M | -3.11% | 1,171,561 | 2.24M |
| 440 | DMAC | DiaMedica Therapeutics Inc. | 539.26M | 7.64% | 302,505 | - |
| 441 | NGNE | Neurogene Inc. | 533.70M | 0.23% | 186,625 | 925.00K |
| 442 | FLGT | Fulgent Genetics, Inc. | 532.97M | 0.41% | 288,991 | 323.93M |
| 443 | ENTX | Entera Bio Ltd. | 530.46M | -1.29% | 136,934 | 42.00K |
| 444 | PBYI | Puma Biotechnology, Inc. | 527.56M | 0.39% | 406,502 | 231.24M |
| 445 | SRZN | Surrozen, Inc. | 526.95M | 3.79% | 117,731 | 11.51M |
| 446 | VALN | Valneva SE | 526.44M | 3.57% | 4,646 | 163.30M |
| 447 | SGHT | Sight Sciences, Inc. | 518.93M | 2.95% | 278,163 | 83.38M |
| 448 | NRC | NRC Health | 510.80M | -0.78% | 108,969 | 143.79M |
| 449 | FTH | Faeth Therapeutics, Inc. | 507.76M | 2.18% | 203,275 | - |
| 450 | ETRA | Electra Therapeutics, Inc. | 506.53M | 10.40% | 927,342 | - |
| 451 | MCTA | Charming Medical Limited | 504.26M | -0.02% | 4,251,392 | 4.81M |
| 452 | RGNX | REGENXBIO Inc. | 503.68M | 6.56% | 854,955 | 174.48M |
| 453 | DCTH | Delcath Systems, Inc. | 499.66M | 0.77% | 386,765 | 95.42M |
| 454 | INDP | Indaptus Therapeutics, Inc. | 497.60M | -7.43% | 111,970 | - |
| 455 | ANGO | AngioDynamics, Inc. | 493.30M | -0.26% | 1,220,210 | 325.38M |
| 456 | AQST | Aquestive Therapeutics, Inc. | 486.99M | 2.92% | 2,085,200 | 48.84M |
| 457 | EOLS | Evolus, Inc. | 486.79M | 2.93% | 440,657 | 316.49M |
| 458 | EVH | Evolent Health, Inc. | 486.16M | -3.37% | 1,262,806 | 2.10B |
| 459 | CAPR | Capricor Therapeutics, Inc. | 479.07M | 13.81% | 4,474,685 | 11.13M |
| 460 | CTMX | CytomX Therapeutics, Inc. | 475.02M | -2.24% | 3,412,273 | 18.30M |
| 461 | MDXG | MiMedx Group, Inc. | 474.26M | -0.91% | 1,578,358 | 303.73M |
| 462 | RCEL | AVITA Medical, Inc. | 474.11M | -0.52% | 532,199 | 75.63M |
| 463 | CERS | Cerus Corporation | 471.57M | -0.85% | 3,497,693 | 226.57M |
| 464 | OCS | Oculis Holding AG | 471.02M | -1.04% | 541,789 | 1.12M |
| 465 | GYRE | Gyre Therapeutics, Inc. | 470.79M | -6.13% | 239,507 | 109.82M |
| 466 | MNPR | Monopar Therapeutics Inc. | 469.11M | 5.45% | 156,137 | - |
| 467 | OVID | Ovid Therapeutics Inc. | 468.71M | 0.42% | 1,375,088 | 1.58M |
| 468 | SENS | Senseonics Holdings, Inc. | 468.46M | -1.34% | 557,048 | 48.55M |
| 469 | SSII | SS Innovations International, Inc. | 466.90M | 0.87% | 40,468 | 52.40M |
| 470 | ARVN | Arvinas, Inc. | 463.59M | -5.72% | 1,802,244 | 275.30M |
| 471 | PHAT | Phathom Pharmaceuticals, Inc. | 455.93M | -3.04% | 2,162,820 | 274.88M |
| 472 | RLMD | Relmada Therapeutics, Inc. | 455.48M | 11.20% | 2,664,747 | - |
| 473 | EPRX | Eupraxia Pharmaceuticals Inc. | 454.41M | 1.78% | 459,248 | - |
| 474 | YDES | YD Bio Limited | 452.97M | 7.12% | 23,343 | 1.24M |
| 475 | TKNO | Alpha Teknova, Inc. | 452.90M | 4.71% | 204,252 | 43.70M |
| 476 | BWAY | BrainsWay Ltd. | 447.79M | 0.54% | 46,538 | 60.70M |
| 477 | MASS | 908 Devices Inc. | 441.03M | 4.51% | 308,564 | 60.84M |
| 478 | CRMD | CorMedix Inc. | 433.37M | 3.15% | 2,459,294 | 462.25M |
| 479 | NPCE | NeuroPace, Inc. | 422.53M | -0.24% | 199,830 | 106.99M |
| 480 | PRTA | Prothena Corporation plc | 421.48M | -0.97% | 289,489 | 54.53M |
| 481 | RZLT | Rezolute, Inc. | 420.64M | 3.35% | 919,347 | - |
| 482 | SI | Shoulder Innovations, Inc. | 412.63M | 2.59% | 131,540 | 60.06M |
| 483 | ASMB | Assembly Biosciences, Inc. | 405.58M | 2.10% | 170,887 | 74.85M |
| 484 | KMDA | Kamada Ltd. | 405.39M | -1.49% | 322,752 | 191.85M |
| 485 | EDIT | Editas Medicine, Inc. | 399.31M | 1.17% | 1,756,655 | 47.01M |
| 486 | ALT | Altimmune, Inc. | 396.82M | 0.99% | 2,397,779 | 31.00K |
| 487 | CCCC | C4 Therapeutics, Inc. | 394.91M | - | 1,585,452 | 35.04M |
| 488 | BLSM | BlossomHill Therapeutics, Inc. | 394.45M | -0.08% | 158,455 | - |
| 489 | CARL | Carlsmed, Inc. | 393.16M | -4.13% | 129,839 | 63.30M |
| 490 | SRTA | Strata Critical Medical, Inc. | 392.79M | 3.74% | 1,870,948 | 280.76M |
| 491 | PRLD | Prelude Therapeutics Incorporated | 389.32M | -1.56% | 174,751 | 22.42M |
| 492 | AVTX | Avalo Therapeutics, Inc. | 388.82M | -0.96% | 1,826,281 | 59.00K |
| 493 | TLRY | Tilray Brands, Inc. | 388.66M | 3.92% | 5,182,962 | 963.10M |
| 494 | ALLO | Allogene Therapeutics, Inc. | 386.95M | 2.75% | 17,666,358 | 4.64M |
| 495 | ZURA | Zura Bio Limited | 384.34M | 1.27% | 1,931,723 | - |
| 496 | MPLT | MapLight Therapeutics, Inc. | 378.47M | 0.44% | 345,413 | - |
| 497 | AUTL | Autolus Therapeutics plc | 376.62M | -0.35% | 2,883,273 | 117.39M |
| 498 | FENC | Fennec Pharmaceuticals Inc. | 375.22M | 1.52% | 135,036 | 59.22M |
| 499 | TECX | Tectonic Therapeutic, Inc. | 371.05M | - | 198,954 | - |
| 500 | TRXB | TRex Bio, Inc. | 369.64M | 0.66% | 146,235 | - |